| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | -0.0039 | 0.9 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | Gemcitabine | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | CX-5461 | GDSC1000 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |